SPRC
SPRC
NASDAQ · Pharmaceuticals

Scisparc Ltd

$4.52
+0.01 (+0.22%)
As of Sep 21, 6:20 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.54M
Net Income
-178,440,599
Gross Margin
73.7%
Profit Margin
-1,422.8%
Rev Growth
-14.1%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.54M 14.60M 1.35M 1.33M
Gross Profit 9.24M 10.76M 772.6K 759.7K
Operating Income -122,691,248 -128,532,328 463.6K 468.3K
Net Income -178,440,599 -186,935,792 424.2K 446.9K
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Rev Growth -14.1% -14.1% -3.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 103.9K 103.9K 970.1K 740.6K
Total Equity 1.24M 1.24M 893.1K 867.5K
D/E Ratio 0.08 0.08 1.09 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -119,263,178 -131,882,224 830.6K 717.6K
Free Cash Flow 355.4K 299.5K